|
|
|
3988
|
*% FREE TESTOSTERONE
|
%
|
|
0.90-3.10
|
0.30-2.60
|
0.30-3.10
|
|
|
|
|
18 - 29 Years
|
1.10-2.80
|
0.70-2.30
|
0.70-2.80
|
|
|
|
|
30 - 39 Years
|
1.00-3.10
|
0.50-2.30
|
0.50-3.10
|
|
|
|
|
40 - 49 Years
|
1.10-2.80
|
0.50-2.30
|
0.50-2.80
|
|
|
|
|
50 - 59 Years
|
0.90-2.50
|
0.60-2.60
|
0.60-2.60
|
|
|
|
|
60 - 69 Years
|
1.50-2.20
|
0.50-2.00
|
0.50-2.20
|
|
|
|
|
70 - 87 Years
|
1.00-2.50
|
0.30-1.40
|
0.30-2.50
|
|
1416
|
A/G RATIO
|
|
|
1.00-2.20
|
1.00-2.20
|
1.00-2.20
|
|
5139
|
*3A-ANDROSTANEDIOL GLC(S)
|
NG/ML
|
|
|
|
|
|
0027
|
ABO GROUPING
|
|
|
|
|
|
|
0178
|
ACE (ANGIOTESN CONV ENZY)
|
ACE/U
|
|
6.0-61.0
|
6.0-61.0
|
6.0-61.0
|
|
4428
|
*ACETAMINOPHEN (S)
|
UG/ML
|
|
10-30
|
10-30
|
10-30
|
|
6110
|
*ACETAMINOPHEN SJCH
|
UG/ML
|
|
<10
|
<10
|
<10
|
|
0001
|
ACETONE SERUM
|
|
|
|
|
NEGATIVE
|
|
6349
|
*ACETONE SERUM (S)
|
ML/DL
|
|
|
|
|
|
4429
|
*ACETYLCH BINDING AABS(S)
|
NMOL/L
|
|
<0.25
|
<0.25
|
<0.25
|
|
5107
|
*ACETYLCH RECEP BLK AA(S)
|
%
|
|
<15
|
<15
|
<15
|
|
5108
|
*ACETYLCH RECEP MOD AA(S)
|
%
|
|
<20
|
<20
|
<20
|
|
1107
|
ACTH
|
PG/ML
|
|
0-46
|
0-46
|
0-49
|
|
5882
|
ADDITIONAL
|
|
|
|
|
|
|
6024
|
ADDITIONAL CHEMS FOR CMP
|
|
|
|
|
|
|
0882
|
ADDITIONAL:
|
|
|
|
|
|
|
5887
|
ADEQUACY
|
|
|
|
|
|
|
0887
|
ADEQUACY:
|
|
|
|
|
|
|
4030
|
*ADH (ANTIDIURETIC HRMN)
|
|
|
|
|
|
|
4938
|
*ADRENAL TOTAL AUTOABS(S)
|
TITER
|
|
|
|
<1:2
|
|
7782
|
AEROBIC ISOL ADDL ID METH
|
|
|
|
|
|
|
7783
|
AEROBIC ISOL, ADDL ID X 2
|
|
|
|
|
|
|
7784
|
AEROBIC ISOL, ADDL ID X 3
|
|
|
|
|
|
|
1531
|
AFB CULTURE, 1ST
|
|
|
|
|
|
|
1564
|
AFB CULTURE, 2ND
|
|
|
|
|
|
|
1565
|
AFB CULTURE, 3RD
|
|
|
|
|
|
|
0719
|
AFB SMEAR
|
|
|
|
|
NEGATIVE
|
|
0797
|
AFB SMEAR #2
|
|
|
|
|
NEGATIVE
|
|
0798
|
AFB SMEAR #3
|
|
|
|
|
NEGATIVE
|
|
1538
|
AFB SMEAR ONLY
|
|
|
|
|
|
|
0732
|
AFB SMEAR X2
|
|
|
|
|
|
|
0733
|
AFB SMEAR X3
|
|
|
|
|
|
|
5615
|
*AFP TUMOR MARKER (S)
|
NG/ML
|
|
<9.0
|
<9.0
|
<9.0
|
|
5100
|
AFTER HOURS FEE
|
|
|
|
|
|
|
0899
|
AFTER HOURS STAT
|
|
|
|
|
|
|
6348
|
*AH50-ALT PATHWAY (S)
|
U/ML
|
|
28-144
|
28-144
|
28-144
|
|
0007
|
ALBUMIN
|
GM/DL
|
|
3.2-5.2
|
3.2-5.2
|
3.2-5.2
|
|
0011
|
ALBUMIN C.S.F.
|
MG/DL
|
|
10.0-30.0
|
10.0-30.0
|
10.0-30.0
|
|
|
|
|
0 - 4 Years
|
16.0-45.0
|
16.0-45.0
|
16.0-45.0
|
|
|
|
|
5 - 30 Years
|
13.0-22.0
|
13.0-22.0
|
13.0-22.0
|
|
|
|
|
31 - 40 Years
|
13.0-27.0
|
13.0-27.0
|
13.0-27.0
|
|
|
|
|
41 - 50 Years
|
14.0-26.0
|
14.0-26.0
|
14.0-26.0
|
|
|
|
|
51 - 99 Years
|
16.0-32.0
|
16.0-32.0
|
16.0-32.0
|
|
1411
|
ALBUMIN ELECTRO.
|
GM/DL
|
|
2.93-5.43
|
2.93-5.43
|
2.93-5.43
|
|
0009
|
ALCOHOL BLOOD
|
MG/DL
|
|
0-10
|
0-10
|
0-10
|
|
0048
|
ALCOHOL LEGAL
|
MG/DL
|
|
0-10
|
0-10
|
0-10
|
|
1209
|
ALCOHOL, URINE
|
MG/DL
|
|
0-10
|
0-10
|
0-10
|
|
4430
|
*ALDOLASE (S)
|
U/L
|
|
<9
|
<9
|
<9
|
|
4000
|
*ALDOSTERONE
|
|
|
|
|
|
|
4119
|
*ALDOSTERONE (S)
|
NG/DL
|
|
<32
|
<32
|
<32
|
|
4120
|
*ALDOSTERONE URINE RDM(S)
|
NG/ML
|
|
|
|
|
|
0260
|
ALKALINE PHOSPH LEUKOCYTE
|
|
|
32-182
|
32-182
|
32-182
|
|
0013
|
ALKALINE PHOSPHATASE
|
IU/L
|
|
50-123
|
39-117
|
39-123
|
|
|
|
|
1 - 12 Months
|
148-308
|
148-308
|
148-308
|
|
|
|
|
1 - 15 Years
|
117-390
|
117-390
|
117-390
|
|
0018
|
ALPHA 1 ANTITRYPSIN
|
MG/DL
|
|
83-199
|
83-199
|
83-199
|
|
1413
|
ALPHA 1 GLOBULIN
|
GM/DL
|
|
0.09-0.29
|
0.09-0.29
|
0.09-0.29
|
|
1414
|
ALPHA 2 GLOBULIN
|
GM/DL
|
|
0.58-1.02
|
0.58-1.02
|
0.58-1.02
|
|
5138
|
*ALPHA SUBUNIT (S)
|
NG/ML
|
|
|
|
|
|
5471
|
*ALPHA-1-ANTI W/O AAT (S)
|
|
|
|
|
|
|
5025
|
*ALPHA-1-ANTITRYPS SLT(S)
|
MG/DL
|
|
<54.01
|
<54.01
|
<54.01
|
|
6452
|
*ALPHA-1-ANTITRYPSIN (S)
|
|
|
|
|
|
|
6040
|
*ALPHA-2-ANTI FUNCT (S)
|
%
|
|
80-120
|
80-120
|
80-120
|
|
5783
|
*ALPHA-2-MACROGLOBULIN(S)
|
MG/DL
|
|
100-310
|
100-310
|
100-310
|
|
0017
|
ALPHA-FETO PROT NON-PG
|
IU/ML
|
|
0.5-5.5
|
0.5-5.5
|
0.5-5.5
|
|
6256
|
*ALPRAZOLAM (S)
|
NG/ML
|
|
5-25
|
5-25
|
5-25
|
|
0386
|
ALT (SGPT)
|
IU/L
|
|
2-45
|
2-45
|
2-45
|
|
4472
|
*ALUMINUM (S)
|
UG/L
|
|
<40
|
<40
|
<40
|
|
5794
|
*ALUMINUM WHOLE BLOOD (S)
|
UG/L
|
|
<20.0
|
<20.0
|
<20.0
|
|
0003
|
AMIKACIN-PEAK
|
UGM/ML
|
|
20.0-25.0
|
20.0-25.0
|
20.0-25.0
|
|
0002
|
AMIKACIN-TROUGH
|
UGM/ML
|
|
2.0-10.0
|
2.0-10.0
|
2.0-10.0
|
|
0021
|
AMMONIA PLASMA
|
UGM/DL
|
|
25-100
|
25-100
|
25-100
|
|
1050
|
*AMMONIA PLASMA - SJH
|
UMOL/L
|
|
11-35
|
11-35
|
11-35
|
|
0023
|
AMPHETAMINE SCREEN
|
|
|
|
|
NEGATIVE
|
|
|
|
|
19 - 165 Years
|
25-115
|
25-115
|
25-115
|
|
0585
|
AMYLASE BODY FLUID
|
U/L
|
|
|
|
|
|
0024
|
AMYLASE SERUM
|
U/L
|
|
28-100
|
28-100
|
28-100
|
|
0025
|
AMYLASE URINE
|
U/L
|
|
0-460
|
0-460
|
0-460
|
|
0038
|
ANA
|
OD RATIO
|
|
<0.90
|
<0.90
|
<0.90
|
|
4342
|
*ANDROSTENEDIONE (S)
|
NG/DL
|
|
|
|
NOT DETECTD
|
|
4501
|
*ANGIOTEN CONV ENZ CSF(S)
|
UNITS
|
|
<10
|
<10
|
<10
|
|
5877
|
*ANGIOTENSIN II (S)
|
NG/L
|
|
8-79
|
8-79
|
8-79
|
|
4502
|
*ANTI DNASE-B (S)
|
U/ML
|
|
<187
|
<187
|
<187
|
|
6107
|
*ANTI RNA POLYMERASE 3(S)
|
UNITS
|
|
<20
|
<20
|
<20
|
|
6312
|
*ANTI-ANNEXIN V IGG (E)
|
AU/ML
|
|
<10
|
<10
|
<10
|
|
6313
|
*ANTI-ANNEXIN V IGM (E)
|
AU/ML
|
|
<18
|
<18
|
<18
|
|
0032
|
ANTIBODY IDENT
|
|
|
|
|
|
|
0030
|
ANTIBODY SCREEN
|
|
|
|
|
NEGATIVE
|
|
0031
|
ANTIBODY TITER
|
TITER
|
|
NEGATIVE
|
NEGATIVE
|
NEGATIVE
|
|
1236
|
ANTI-CARDIOLIPIN IGA
|
UNITS/ML
|
|
<8.0
|
<8.0
|
<8.0
|
|
1232
|
ANTI-CARDIOLIPIN IGG
|
UNITS/ML
|
|
<10.0
|
<10.0
|
<10.0
|
|
1231
|
ANTI-CARDIOLIPIN IGM
|
UNITS/ML
|
|
<10.0
|
<10.0
|
<10.0
|
|
4260
|
*ANTIDIURETIC HORMONE (S)
|
PG/ML
|
|
<9.0
|
<9.0
|
<9.0
|
|
0681
|
ANTI-DNA,DS
|
IU/ML
|
|
<25.0
|
<25.0
|
<25.0
|
|
3994
|
*ANTI-ENDOMYSIAL IGA
|
|
|
|
|
NEGATIVE
|
|
1227
|
ANTIGEN TYPING MISC
|
|
|
|
|
|
|
1228
|
ANTIGEN TYPING MISC 2
|
|
|
|
|
|
|
1229
|
ANTIGEN TYPING MISC 3
|
|
|
|
|
|
|
1197
|
ANTIGEN TYPING MISC 4
|
|
|
|
|
|
|
1198
|
ANTIGEN TYPING MISC 5
|
|
|
|
|
|
|
4033
|
*ANTI-IGA AB, IGG, SERUM
|
UNITS
|
|
<100
|
<100
|
<100
|
|
0067
|
ANTI-MICROSOME (TPO)
|
IU/ML
|
|
0-34
|
0-34
|
0-34
|
|
0279
|
ANTI-MITOCHONDRIAL AB
|
U/ML
|
|
0.00-10.00
|
0.00-10.00
|
0.00-10.00
|
|
1239
|
ANTI-PHOSPHATIDYLSERN IGG
|
GPS
|
|
<16.00
|
<16.00
|
<16.00
|
|
1240
|
ANTI-PHOSPHATIDYLSERN IGM
|
MPS
|
|
<22.00
|
<22.00
|
<22.00
|
|
0242
|
ANTI-SM
|
EU/ML
|
|
<16
|
<16
|
<16
|
|
1910
|
ANTI-SMOOTH MUSCLE
|
EU
|
|
<20
|
<20
|
<20
|
|
0257
|
ANTI-SSA
|
EU/ML
|
|
<16
|
<16
|
<16
|
|
0278
|
ANTI-SSB
|
EU/ML
|
|
<16
|
<16
|
<16
|
|
0068
|
ANTI-THYROGLOBULIN
|
IU/ML
|
|
0-40
|
0-40
|
0-40
|
|
5524
|
*APOLIPOPROTEIN A-1 (S)
|
MG/DL
|
|
128-276
|
128-276
|
128-276
|
|
4001
|
*APOLIPOPROTEIN B
|
|
|
46-174
|
46-174
|
46-174
|
|
|
|
|
18 - 165 Years
|
46-174
|
|
|
|
4503
|
*APOLIPOPROTEIN B (S)
|
MG/DL
|
|
40-130
|
40-130
|
40-130
|
|
0459
|
APTT 1:1 NORMAL 2HR @ 37C
|
SECONDS
|
|
21.7-32.4
|
21.7-32.4
|
21.7-32.4
|
|
0320
|
A-PTT 1:1 NORMAL PLASMA
|
SECONDS
|
|
21.7-32.4
|
21.7-32.4
|
21.7-32.4
|
|
0321
|
A-PTT 1:1 SALINE
|
SECONDS
|
|
21.7-32.4
|
21.7-32.4
|
21.7-32.4
|
|
4261
|
*ARIPIPRAZOLE [0451SP](S)
|
NG/ML
|
|
|
|
|
|
5897
|
*ARRAY CGH (S)
|
|
|
|
|
|
|
4123
|
*ARSENIC WHOLE BLOOD (S)
|
UG/L
|
|
<11.0
|
<11.0
|
<11.0
|
|
5095
|
*ASHKENAZI GENOTYPR (S)
|
|
|
|
|
|
|
0035
|
ASOT (ANTISTREPTO TITER)
|
IU/L
|
|
0-125
|
0-125
|
0-125
|
|
5804
|
*ASPERGILLUS FUMIG IGG(S)
|
|
|
<2.0
|
<2.0
|
<2.0
|
|
5072
|
*ASPERGILLUS GALACT AG(S)
|
INDEX
|
|
<0.5
|
<0.5
|
<0.5
|
|
4262
|
*ASPERGILLUS IGG ABS (S)
|
INDEX
|
|
<0.81
|
<0.81
|
<0.81
|
|
5510
|
*ASPERGILLUS IGM ABS (S)
|
INDEX
|
|
<300
|
<300
|
<0.81
|
|
0385
|
AST (SGOT)
|
IU/L
|
|
2-50
|
2-50
|
2-50
|
|
1036
|
AT3 ANTIGEN
|
mg/dL
|
|
24.9-33.1
|
24.9-33.1
|
24.9-33.1
|
|
1176
|
AT3 FUNCTIONAL
|
%
|
|
85-120
|
85-120
|
85-120
|
|
9000
|
AUTOPSY G & M W/O CNS
|
|
|
|
|
|
|
9001
|
AUTOPSY G & M WITH BRAIN
|
|
|
|
|
|
|
4002
|
*BABESIA MICROTI AB
|
|
|
|
|
NEG
|
|
4805
|
*BABESIO MICROTI IGG (S)
|
TITER
|
|
|
|
<1:16
|
|
3721
|
BACTI - WET MOUNT
|
|
|
|
|
|
|
0950
|
BALANCE FORWARD 01/01/94
|
|
|
|
|
|
|
0949
|
BALANCE FWD 01/01/94
|
|
|
|
|
|
|
0026
|
BARBITURATE URINE
|
|
|
|
|
NEGATIVE
|
|
1188
|
*-BASE EXCESS - SJCH
|
MMOL/L
|
|
-3.0 TO 3.0
|
-3.0 TO 3.0
|
-3.0 TO 3.0
|
|
1164
|
BASOPHILS %
|
%
|
|
0.4-2.2
|
0.4-2.2
|
0.4-2.2
|
|
1162
|
BASOPHILS ABSOLUTE
|
1000/CMM
|
|
0.0-0.4
|
0.0-0.4
|
0.0-0.4
|
|
5200
|
*BCR/ABL ULT QNT MAJ(S)
|
RATIO
|
|
|
|
|
|
5199
|
*BCR/ABL ULT QNT MIN(S)
|
RATIO
|
|
|
|
|
|
5501
|
*BCR/ABL1 GENE REARRNG(S)
|
|
|
|
|
|
|
0046
|
BENZODIAZEPINES
|
|
|
|
|
NEGATIVE
|
|
4201
|
*BENZODIAZEPINES 90124(S)
|
|
|
|
|
|
|
1412
|
BETA GLOBULIN
|
GM/DL
|
|
0.63-1.13
|
0.63-1.13
|
0.63-1.13
|
|
1526
|
BETA STREP SCREEN
|
|
|
|
|
|
|
4134
|
*BETA-2-MICROGLOB SRM (S)
|
MG/L
|
|
<2.0
|
<2.0
|
<2.0
|
|
5806
|
*BETA-HYDROXYBUTYRATE (S)
|
MMOL/L
|
|
0.02-0.27
|
0.02-0.27
|
0.02-0.27
|
|
8000
|
BETHESDA TEST
|
|
|
|
|
|
|
5225
|
*BICARBONATE URINE (S)
|
MOLAR
|
|
|
|
|
|
5861
|
*BILE ACID, TOTAL (S)
|
UMOL/L
|
|
0.9-9.0
|
0.9-9.0
|
0.9-9.0
|
|
0054
|
BILIRUBIN DIRECT
|
MG/DL
|
|
0.1-0.3
|
0.1-0.3
|
0.1-0.3
|
|
0055
|
BILIRUBIN TOTAL
|
MG/DL
|
|
0.2-1.3
|
0.2-1.3
|
0.2-1.3
|
|
|
|
|
0 - 1 Months
|
0.2-8.0
|
0.2-8.0
|
0.2-8.0
|
|
|
|
|
0 - 1 Days
|
0.2-8.0
|
0.2-8.0
|
0.2-8.0
|
|
|
|
|
2 - 5 Days
|
0.2-14.0
|
0.2-14.0
|
0.2-14.0
|
|
|
|
|
6 - 20 Days
|
0.2-11.0
|
0.2-11.0
|
0.2-11.0
|
|
|
|
|
21 - 31 Days
|
0.2-8.0
|
0.2-8.0
|
0.2-8.0
|
|
0514
|
BILLING FEE #2
|
|
|
|
|
|
|
5784
|
*BLADDER CANCER-FISH (S)
|
|
|
|
|
|
|
0056
|
BLEEDING TIME TEMPLATE
|
MINUTES
|
|
3.00-9.00
|
3.00-9.00
|
3.00-9.00
|
|
1523
|
BLOOD CULTURE, 1ST
|
|
|
|
|
|
|
1524
|
BLOOD CULTURE, 2ND
|
|
|
|
|
|
|
1525
|
BLOOD CULTURE, 3RD
|
|
|
|
|
|
|
1199
|
BLOOD DRAW-ARTERIAL
|
|
|
|
|
|
|
0155
|
BLOOD DRAW-VENOUS
|
|
|
|
|
|
|
1136
|
BLOOD SMEAR PHYS CONSULT
|
|
|
|
|
|
|
1291
|
BNP (B-TYPE NAT PEP)
|
PG/ML
|
|
<100
|
<100
|
<100
|
|
2504
|
*BNP (B-TYPE NAT PEP)SJCH
|
|
|
<100
|
<100
|
<1000
|
|
1522
|
BODY FLUID CULTURE
|
|
|
|
|
|
|
9231
|
BONE MARROW ASP NEEDLE B1
|
|
|
|
|
|
|
9232
|
BONE MARROW ASP NEEDLE B2
|
|
|
|
|
|
|
9233
|
BONE MARROW ASP NEEDLE B3
|
|
|
|
|
|
|
9234
|
BONE MARROW ASP NEEDLE B4
|
|
|
|
|
|
|
0937
|
BONE MARROW ASP ONLY
|
|
|
|
|
|
|
9371
|
BONE MARROW ASP ONLY-1
|
|
|
|
|
|
|
9372
|
BONE MARROW ASP ONLY-2
|
|
|
|
|
|
|
9373
|
BONE MARROW ASP ONLY-3
|
|
|
|
|
|
|
0922
|
BONE MARROW ASPIR-INTER
|
|
|
|
|
|
|
9916
|
BONE MARROW BILL ONLY
|
|
|
|
|
|
|
9241
|
BONE MARROW FE STAIN 1
|
|
|
|
|
|
|
9242
|
BONE MARROW FE STAIN 2
|
|
|
|
|
|
|
9243
|
BONE MARROW FE STAIN 3
|
|
|
|
|
|
|
9244
|
BONE MARROW FE STAIN 4
|
|
|
|
|
|
|
9245
|
BONE MARROW FE STAIN 5
|
|
|
|
|
|
|
9246
|
BONE MARROW FE STAIN 6
|
|
|
|
|
|
|
9247
|
BONE MARROW FE STAIN 7
|
|
|
|
|
|
|
9248
|
BONE MARROW FE STAIN 8
|
|
|
|
|
|
|
9249
|
BONE MARROW FE STAIN 9
|
|
|
|
|
|
|
0921
|
BONE MARROW INTERPRET
|
|
|
|
|
|
|
0923
|
BONE MARROW NEEDLE BIOPSY
|
|
|
|
|
|
|
9221
|
BONE MARROW SECTION 1
|
|
|
|
|
|
|
1894
|
BONE MARROW SECTION 1 PC
|
|
|
|
|
|
|
1895
|
BONE MARROW SECTION 1 TC
|
|
|
|
|
|
|
9222
|
BONE MARROW SECTION 2
|
|
|
|
|
|
|
1896
|
BONE MARROW SECTION 2 PC
|
|
|
|
|
|
|
1897
|
BONE MARROW SECTION 2 TC
|
|
|
|
|
|
|
9223
|
BONE MARROW SECTION 3
|
|
|
|
|
|
|
1898
|
BONE MARROW SECTION 3 PC
|
|
|
|
|
|
|
1899
|
BONE MARROW SECTION 3 TC
|
|
|
|
|
|
|
9224
|
BONE MARROW SECTION 4
|
|
|
|
|
|
|
1900
|
BONE MARROW SECTION 4 PC
|
|
|
|
|
|
|
1901
|
BONE MARROW SECTION 4 TC
|
|
|
|
|
|
|
9212
|
BONE MARROW SMEAR INT-2
|
|
|
|
|
|
|
9213
|
BONE MARROW SMEAR INT-3
|
|
|
|
|
|
|
9211
|
BONE MARROW SMEAR INTERP1
|
|
|
|
|
|
|
0924
|
BONE MARROW STAIN & INTER
|
|
|
|
|
|
|
0940
|
BONE MARROW TRAY
|
|
|
|
|
|
|
9400
|
BONE MARROW TRAY-1
|
|
|
|
|
|
|
9401
|
BONE MARROW TRAY-2
|
|
|
|
|
|
|
9214
|
BONE MARRROW INTERPRET-4
|
|
|
|
|
|
|
4504
|
*BORDETELLA PERT IGG (S)
|
INDEX
|
|
<0.81
|
<0.81
|
<0.81
|
|
4508
|
*BORDETELLA PERT IGM (S)
|
INDEX
|
|
<0.81
|
<0.81
|
<0.81
|
|
1999
|
BR 27.29
|
U/ML
|
|
6.4-38.6
|
6.4-38.6
|
6.4-38.6
|
|
4514
|
*BRUCELLA IGG ABS (S)
|
INDEX
|
|
<0.8
|
<0.8
|
<0.8
|
|
|
|
|
21 - 31 Days
|
6-22
|
6-22
|
6-22
|
|
6268
|
*BUSPAR (S)
|
NG/ML
|
|
|
|
|
|
6295
|
*BV/VAG PANEL DNA PRB (Q)
|
|
|
<0.35
|
<0.35
|
|
|
0879
|
C DIFF TOXINS A AND/OR B
|
|
|
|
|
NEGATIVE
|
|
0877
|
C DIFF TOXINS A/B #2
|
|
|
<1.30
|
<1.30
|
NEGATIVE
|
|
0878
|
C DIFF TOXINS A/B #3
|
|
|
|
|
NEGATIVE
|
|
4515
|
*C1 ESTERASE INHIB FNC(S)
|
%
|
|
>67
|
>67
|
>67
|
|
5192
|
*C1Q BINDING IMM CMPLX(S)
|
UG EQ/ML
|
|
<3.2
|
<3.2
|
<3.2
|
|
5373
|
*C22:1N9 (S)
|
UG/ML
|
|
|
|
|
|
0051
|
C-3 COMPLEMENT
|
MG/DL
|
|
88-201
|
88-201
|
88-201
|
|
6347
|
*C3A DESARG FRAGMENT (S)
|
NG/ML
|
|
138-205
|
138-205
|
138-205
|
|
5142
|
*C4 BINDING PROTEIN (S)
|
MG/L
|
|
246-510
|
246-510
|
246-510
|
|
0053
|
C-4 COMPLEMENT
|
MG/DL
|
|
13-47
|
13-47
|
13-47
|
|
4274
|
*CA 15-3 (S)
|
U/ML
|
|
<53
|
<53
|
<53
|
|
0767
|
CA 19-9
|
U/ML
|
|
0.0-35.0
|
0.0-35.0
|
0.0-35.0
|
|
0769
|
CA-125
|
U/ML
|
|
0.0-21.0
|
0.0-21.0
|
0.0-21.0
|
|
5236
|
*CADMIUM, WHOLE BLOOD (S)
|
UG/L
|
|
<5.0
|
<5.0
|
<5.0
|
|
6214
|
*CAFFEINE (S)
|
UG/ML
|
|
|
|
|
|
4516
|
*CALCITONIN (S)
|
PG/ML
|
|
<13.0
|
<13.0
|
<13.0
|
|
0071
|
CALCIUM
|
MG/DL
|
|
8.4-10.2
|
8.4-10.2
|
8.4-10.2
|
|
|
|
|
0 - 10 Days
|
7.6-10.4
|
7.6-10.4
|
7.6-10.4
|
|
|
|
|
11 - 31 Days
|
9.0-11.0
|
9.0-11.0
|
9.0-11.0
|
|
|
|
|
1 - 24 Months
|
9.0-11.0
|
9.0-11.0
|
9.0-11.0
|
|
|
|
|
2 - 12 Years
|
8.8-10.8
|
8.8-10.8
|
8.8-10.8
|
|
0424
|
CALCIUM IONIZED
|
MMOL/L
|
|
1.19-1.30
|
1.19-1.30
|
1.19-1.30
|
|
0076
|
CALCIUM URINE
|
MG/DL
|
|
|
|
|
|
1925
|
CALCIUM/PHOS PRODUCTS
|
|
|
|
|
|
|
6012
|
*CALPROTECTIN (S)
|
MCG/G
|
|
<51
|
<51
|
<51
|
|
6438
|
*CANAVAN DISEASE GENO (S)
|
|
|
|
|
|
|
1224
|
C-ANCA (PR-3)
|
INDEX
|
|
<0.80
|
<0.80
|
<0.80
|
|
4003
|
*CANDIDA AB PROFILE
|
|
|
|
|
|
|
5990
|
*CANDIDA AG DETECTION (S)
|
|
|
<1:16
|
<1:16
|
<1:2
|
|
6296
|
*CANDIDA ALBICANS IGG (S)
|
|
|
|
|
|
|
6450
|
*CANNABINOIDS CONFM UR(S)
|
NG/ML
|
|
<15.0
|
<15.0
|
<15.0
|
|
0074
|
CAPILLARY FRAGILITY
|
PET/SQCM
|
|
0-5
|
0-5
|
0-5
|
|
5234
|
*CARBAMAZEPINE FREE (S)
|
MCG/ML
|
|
0.5-2.7
|
0.5-2.7
|
0.5-2.7
|
|
0075
|
CARBON DIOXIDE
|
MEQ/L
|
|
22-30
|
22-30
|
22-30
|
|
0453
|
*CARBOXY HGB (M)
|
%
|
|
0.0-1.5
|
0.0-1.5
|
0.0-1.5
|
|
4700
|
*CARBOXYHEMOGLOBIN (S)
|
|
|
|
|
|
|
6009
|
.CBC FOR USE W/TEST 1025
|
|
|
|
|
|
|
1366
|
.CBC W/DIFF-MCR
|
|
|
|
|
|
|
0561
|
CCP IGG ELISA
|
UNITS
|
|
<20.00
|
<20.00
|
<20.00
|
|
0444
|
CD3 (ABSOLUTE)
|
/CUMM
|
|
688-1955
|
688-1955
|
688-1955
|
|
0446
|
CD4 (ABSOLUTE)
|
/CUMM
|
|
355-1213
|
470-1298
|
355-1298
|
|
5014
|
*CD4 SURFACE MARKER (S)
|
%
|
|
32-64
|
32-64
|
32-64
|
|
|
|
|
1 - 31 Days
|
34-57
|
34-57
|
34-57
|
|
|
|
|
1 - 12 Months
|
34-57
|
34-57
|
34-57
|
|
|
|
|
1 - 13 Years
|
34-57
|
34-57
|
34-57
|
|
|
|
|
14 - 165 Years
|
32-64
|
32-64
|
32-64
|
|
0448
|
CD8 (ABSOLUTE)
|
/CUMM
|
|
144-796
|
144-796
|
144-796
|
|
|
|
|
18 - 40 Years
|
208-796
|
208-796
|
208-796
|
|
|
|
|
41 - 65 Years
|
144-699
|
144-699
|
144-699
|
|
0080
|
CEA - MSA
|
NG/ML
|
|
0.0-3.0
|
0.0-3.0
|
0.0-3.0
|
|
5740
|
*CELIAC DISEASE GENO (S)
|
|
|
|
|
|
|
0624
|
*CELIAC PANEL (P)
|
MEQ/DAY
|
|
80-220
|
80-220
|
|
|
0683
|
*CELIAC PLUS PANEL (a)
|
|
|
|
|
|
|
0657
|
*CELIAPLUSUS CONF (P)
|
|
|
|
|
|
|
0360
|
CELL COUNT RBC
|
/CU MM
|
|
|
|
|
|
0380
|
CELL COUNT WBC W/DIFF
|
/CU MM
|
|
|
|
|
|
0359
|
CELL COUNT WBC W/O DIFF
|
/CU MM
|
|
|
|
|
|
0111
|
CELL TYPING/MISC
|
|
|
|
|
|
|
7100
|
CENTRIFUGE CHARGE
|
|
|
|
|
|
|
0070
|
CENTROMERE (ANTI)
|
EU
|
|
<20
|
<20
|
<20
|
|
1519
|
CERTIS CULTURE
|
|
|
|
|
|
|
2000
|
CERULOPLASMIN
|
MG/DL
|
|
25-63
|
25-63
|
25-63
|
|
0551
|
CHLAMYDIA BY PCR
|
|
|
|
|
NEGATIVE
|
|
0684
|
CHLAMYDIA BY PCR (TP)
|
|
|
|
|
NEGATIVE
|
|
1351
|
CHLAMYDIA BY PCR (UA)
|
|
|
|
|
NEGATIVE
|
|
0972
|
CHLAMYDIA PNEUMONIAE IGA
|
|
|
|
|
<1:16
|
|
0327
|
CHLAMYDIA PNEUMONIAE IGG
|
|
|
|
|
<1:16
|
|
0328
|
CHLAMYDIA PNEUMONIAE IGM
|
|
|
|
|
<1:10
|
|
0973
|
CHLAMYDIA PSITTACI IGA
|
|
|
|
|
<1:16
|
|
0468
|
CHLAMYDIA PSITTACI IGG
|
|
|
|
|
<1:16
|
|
0469
|
CHLAMYDIA PSITTACI IGM
|
|
|
|
|
<1:10
|
|
5224
|
*CHLAMYDIA RRNA DETECT(S)
|
|
|
|
|
NOT DETECTD
|
|
4525
|
*CHLAMYDIA TRAC IGM AB(S)
|
TITER
|
|
<5.0
|
<5.0
|
<1:10
|
|
|
|
|
18 - 165 Years
|
<0.02
|
<0.02
|
NOTDETECTED
|
|
0974
|
CHLAMYDIA TRACHOMATIS IGA
|
|
|
|
|
<1:16
|
|
0482
|
CHLAMYDIA TRACHOMATIS IGG
|
|
|
|
|
<1:16
|
|
0483
|
CHLAMYDIA TRACHOMATIS IGM
|
|
|
|
|
<1:10
|
|
0086
|
CHLORIDE
|
MEQ/L
|
|
98-108
|
98-108
|
98-108
|
|
0630
|
CHLORIDE URINE
|
MEQ/L
|
|
170-250
|
170-250
|
170-250
|
|
5807
|
*CHLORPROMAZINE (S)
|
NG/ML
|
|
|
|
|
|
0091
|
CHOLESTEROL
|
MG/DL
|
|
130-200
|
130-200
|
130-200
|
|
|
|
|
0 - 29 Years
|
120-200
|
120-200
|
120-200
|
|
|
|
|
30 - 39 Years
|
140-200
|
140-200
|
140-200
|
|
|
|
|
40 - 49 Years
|
150-200
|
150-200
|
150-200
|
|
|
|
|
50 - 99 Years
|
160-200
|
160-200
|
160-200
|
|
0282
|
CHOLESTEROL SCREEN
|
MG/DL
|
|
130-200
|
130-200
|
130-200
|
|
0084
|
CHOLESTEROL-HDL
|
MG/DL
|
|
>40
|
>40
|
>40
|
|
0306
|
CHOLINESTERASE PLASMA
|
|
|
1700-5778
|
1700-5778
|
1700-5778
|
|
0095
|
CHOLINESTERASE SERUM
|
U/L @37C
|
|
3167-6333
|
3167-6333
|
3167-6333
|
|
0304
|
CHOLINESTERASE WHOLE BLD
|
|
|
|
|
|
|
4526
|
*CHROMATIN IGG AABS (S)
|
EIA UNIS
|
|
<20
|
<20
|
<20
|
|
5686
|
*CHROMIUM BLOOD (S)
|
UG/L
|
|
0.5-5.0
|
0.5-5.0
|
0.5-5.0
|
|
4281
|
*CHROMOGRANIN-A (S)
|
U/L
|
|
0.08-0.80
|
0.08-0.80
|
|
|
4698
|
*CHROMOSOME ANL (CONG)(S)
|
|
|
|
|
|
|
4699
|
*CHROMOSOME ANL (LEUK)(S)
|
|
|
|
|
|
|
4759
|
*CHROMOSOME ANLS:SKIN (S)
|
|
|
|
|
|
|
0961
|
CLINICAL DATA:
|
|
|
|
|
|
|
0497
|
CLO TEST
|
|
|
|
|
NEGATIVE
|
|
5220
|
*CLONAZEPAM (S)
|
NG/ML
|
|
20-60
|
20-60
|
20-60
|
|
4814
|
*CLONIDINE (S)
|
NG/ML
|
|
|
|
|
|
0073
|
CLOT RETRACTION
|
%
|
|
50-100
|
50-100
|
50-100
|
|
0081
|
CMV ANTIBODY-IGG
|
INDEX
|
|
<0.80
|
<0.80
|
<0.80
|
|
0082
|
CMV ANTIBODY-IGM
|
INDEX
|
|
0.00-0.89
|
0.00-0.89
|
0.00-0.89
|
|
4548
|
*CMV IGG ABS CSF (S)
|
INDEX
|
|
<0.8
|
<0.8
|
<0.8
|
|
4547
|
*CMV IGM ABS CSF (S)
|
INDEX
|
|
|
|
<0.8
|
|
4984
|
*CMV PCR ULTRAQUANT (S)
|
COPY/ML
|
|
<100
|
<100
|
<100
|
|
8999
|
CO. C TO CO. 1
|
|
|
|
|
|
|
5808
|
*CO Q10 ASSESSR (S)
|
MG/L
|
|
0.5-1.8
|
0.5-1.8
|
0.5-1.8
|
|
0087
|
COCAINE METABOLITE
|
|
|
|
|
NEGATIVE
|
|
4056
|
*COCAINE METABOLITES (S)
|
INDEX
|
|
>1.000
|
>1.000
|
>1.000
|
|
1185
|
COCCI AB IgG (EIA)
|
|
|
|
|
NEGATIVE
|
|
1184
|
COCCI AB IgM (EIA)
|
|
|
0-55
|
0-55
|
NEGATIVE
|
|
0431
|
*COCCI CF TITER (C)
|
|
|
|
|
|
|
1359
|
COCCI IgG (ID)
|
|
|
|
|
NEGATIVE
|
|
1362
|
COCCI IgM (ID)
|
|
|
|
|
NEGATIVE
|
|
0436
|
*COCCI IMMUNODIFF (C)
|
|
|
|
|
|
|
0432
|
*COCCI PPT (EIA-IGM) (C)
|
|
|
|
|
|
|
0581
|
*COCCI SEROLOGY
|
|
|
|
|
|
|
5789
|
*COCCIDIOIDES AB (S)
|
|
|
>0.150
|
>0.150
|
NEGATIVE
|
|
5791
|
*COCCIDIOIDES AB IGM (S)
|
IV
|
|
|
|
|
|
5790
|
*COCCIDIOIDES TOTAL AB(S)
|
|
|
|
|
<1:2
|
|
6274
|
*CODEINE SERUM (S)
|
NG/ML
|
|
10-100
|
10-100
|
10-100
|
|
0100
|
COLD AGGLUTININS
|
TITER
|
|
<1:32
|
<1:32
|
<1:32
|
|
0102
|
COLLECTION SPEC HANDLING
|
|
|
|
|
|
|
1131
|
COLOR
|
|
|
|
|
PALE YELLOW
|
|
5883
|
COMMENTS
|
|
|
|
|
|
|
0883
|
COMMENTS:
|
|
|
|
|
|
|
1364
|
COMP FIXATION TITER IGG
|
|
|
|
|
|
|
0129
|
COMPATABILITY-ANTIGLOB.
|
|
|
|
|
|
|
0128
|
COMPATABILITY-INCUBATION
|
|
|
70-130
|
70-130
|
|
|
0531
|
COMPATIBILITY TEST-IMMED2
|
|
|
|
|
|
|
0534
|
COMPATIBILITY TEST-IMMED3
|
|
|
|
|
|
|
0537
|
COMPATIBILITY TEST-IMMED4
|
|
|
|
|
|
|
0541
|
COMPATIBILITY TEST-IMMED5
|
|
|
|
|
|
|
0533
|
COMPATIBILITY-ANTIGLOB.2
|
